IN8BIO, INC. Shares Issued
IN8BIO, INC. (INAB) had Shares Issued of 9.85 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares, Issued 9.85M shares.
- 2026-03-31: Common Stock, Shares, Issued 9.85M shares.
- 2025-12-31: Common Stock, Shares, Issued 9.77M shares.
- 2025-09-30: Common Stock, Shares, Issued 4.59M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 9.85M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 9.85M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 9.77M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 4.59M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 4.08M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 81.26M shares 10-Q · filed 2025-05-07 | |
| 2024-12-31 | 2.42M shares 10-K · filed 2026-03-12 | 72.48M shares 10-K · filed 2025-03-13 |
| 2024-09-30 | 46.79M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 46.43M shares 10-Q · filed 2024-08-08 | |
| 2023-12-31 | 43.29M shares 10-K · filed 2025-03-13 | |
| 2023-09-30 | 31.98M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 30.61M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 24.96M shares 10-Q · filed 2023-05-12 | |
| 2022-12-31 | 24.55M shares 10-K · filed 2024-03-14 | |
| 2022-09-30 | 24.50M shares 10-Q · filed 2022-11-10 | |
| 2022-08-11 | 5.39M shares 10-Q · filed 2022-08-12 | |
| 2022-06-30 | 18.84M shares 10-Q · filed 2022-08-12 | |
| 2022-03-31 | 18.81M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 18.78M shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | 18.75M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 3.76M shares 10-Q · filed 2021-09-10 | |
| 2020-12-31 | 3.76M shares 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |